---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-029223"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2021-11-18T23:59:59+00:00"
generated_at: "2026-06-28T07:14:10.983454+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences appoints Avani Kanubaddi as President, lowers quorum to one-third

## Summary
- Avani Kanubaddi, current COO since Dec 2020, appointed President effective Nov 15, 2021.
- Board approved amendment to bylaws reducing stockholder quorum from majority to one-third.
- Kanubaddi previously COO at NEXGEL and founder of Welmedix Healthcare.
- Amendment is effective Nov 15, 2021; full text filed as Exhibit 3.1.

## SEC filing metadata
- accession: 0001493152-21-029223
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2021-11-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/0001493152-21-029223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-029223
- JSON: https://secwatch.observer/filing/0001493152-21-029223.json
- Plain text: https://secwatch.observer/filing/0001493152-21-029223.txt

## Key facts
- Executive change
  Avani Kanubaddi was appointed as President at Enveric Biosciences, Inc..
  - Action: appointed
  - Role: President
  source text: On November 15, 2021, Enveric Biosciences, Inc. (the “Company”) appointed Avani Kanubaddi, the Chief Operating Officer of the Company, to serve as the Company’s President, effective as of November 15, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/0001493152-21-029223-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.